Issue Date | Title | Author(s) |
2021-02-04 | Rutin-loaded liquid crystalline nanoparticles attenuate oxidative stress in bronchial epithelial cells: a PCR validation. | Mehta, M; Paudel, KR; Shukla, SD; Shastri, MD; Satija, S; Singh, SK; Gulati, M; Dureja, H; Zacconi, FC; Hansbro, PM; Chellappan, DK; Dua, K |
2020-10-30 | Antiproliferative effects of boswellic acids-loaded chitosan nanoparticles on human lung cancer cell line A549. | Solanki, N; Mehta, M; Chellappan, DK; Gupta, G; Hansbro, NG; Tambuwala, MM; Aa Aljabali, A; Paudel, KR; Liu, G; Satija, S; Hansbro, PM; Dua, K; Dureja, H |
2020-10-05 | Targeting interleukins in chronic airway diseases using advanced drug delivery. | Satija, S; Mehta, M; Gupta, G; Chellappan, DK; Dua, K |
2021-10-01 | Can dextran-based nanoparticles mitigate inflammatory lung diseases? | Prasher, P; Sharma, M; R Wich, P; Jha, NK; Singh, SK; Chellappan, DK; Dua, K |
2021-07-18 | Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition? | Esh, CJ; Chrismas, BCR; Mauger, AR; Taylor, L |
- | Toward the cholinesterase inhibition potential of TADDOL derivatives: Seminal biological and computational studies | Constantino, AR; Charbe, N; Duarte, Y; Gutiérrez, M; Giordano, A; Prasher, P; Dua, K; Mandolesi, S; Zacconi, FC |
- | Exploring ACSL4/LPCAT3/ALOX15 and SLC7A11/GPX4/NFE2L2 as potential targets in ferroptosis-based cancer therapy | Gupta, G; Bhat, AA; Goyal, A; Singla, N; Gupta, S; Sharma, S; Bhatt, S; Dua, K |
2021-05-05 | Advanced drug delivery systems targeting NF-κB in respiratory diseases | Prasher, P; Sharma, M; Chellappan, DK; Gupta, G; Jha, NK; Singh, SK; MacLoughlin, R; Pinto, TJA; Lobenberg, R; Dua, K |
2020-09 | Vesicular drug delivery systems as theranostics in COVID-19. | Satija, S; Mehta, M; Sharma, M; Prasher, P; Gupta, G; Chellappan, DK; Dua, K |
2020-10-15 | Sugar-based nanoparticles for respiratory diseases: a new paradigm in the nanoworld. | Chan, Y; Ng, SW; Mehta, M; Gupta, G; Chellappan, DK; Dua, K |